505 related articles for article (PubMed ID: 30274195)
1. Biocompatible Fe-Based Micropore Metal-Organic Frameworks as Sustained-Release Anticancer Drug Carriers.
Leng X; Dong X; Wang W; Sai N; Yang C; You L; Huang H; Yin X; Ni J
Molecules; 2018 Sep; 23(10):. PubMed ID: 30274195
[TBL] [Abstract][Full Text] [Related]
2. Investigation of Metal-Organic Framework-5 (MOF-5) as an Antitumor Drug Oridonin Sustained Release Carrier.
Chen G; Luo J; Cai M; Qin L; Wang Y; Gao L; Huang P; Yu Y; Ding Y; Dong X; Yin X; Ni J
Molecules; 2019 Sep; 24(18):. PubMed ID: 31527488
[TBL] [Abstract][Full Text] [Related]
3. Biocompatible MIL-101(Fe) as a Smart Carrier with High Loading Potential and Sustained Release of Curcumin.
Karimi Alavijeh R; Akhbari K
Inorg Chem; 2020 Mar; 59(6):3570-3578. PubMed ID: 32091212
[TBL] [Abstract][Full Text] [Related]
4. Morphology- and size-controlled synthesis of a metal-organic framework under ultrasound irradiation: An efficient carrier for pH responsive release of anti-cancer drugs and their applicability for adsorption of amoxicillin from aqueous solution.
Abazari R; Reza Mahjoub A; Slawin AMZ; Carpenter-Warren CL
Ultrason Sonochem; 2018 Apr; 42():594-608. PubMed ID: 29429708
[TBL] [Abstract][Full Text] [Related]
5. Iron-based porous metal-organic frameworks with crop nutritional function as carriers for controlled fungicide release.
Shan Y; Cao L; Muhammad B; Xu B; Zhao P; Cao C; Huang Q
J Colloid Interface Sci; 2020 Apr; 566():383-393. PubMed ID: 32018178
[TBL] [Abstract][Full Text] [Related]
6. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
7. Metal-organic frameworks, NH
Kim SN; Park CG; Huh BK; Lee SH; Min CH; Lee YY; Kim YK; Park KH; Choy YB
Acta Biomater; 2018 Oct; 79():344-353. PubMed ID: 30134206
[TBL] [Abstract][Full Text] [Related]
8. Metal organic frameworks as a drug delivery system for flurbiprofen.
Al Haydar M; Abid HR; Sunderland B; Wang S
Drug Des Devel Ther; 2017; 11():2685-2695. PubMed ID: 28979098
[TBL] [Abstract][Full Text] [Related]
9. Glutathione responsive cubic gel particles cyclodextrin metal-organic frameworks for intracellular drug delivery.
Xue Q; Ye C; Zhang M; Hu X; Cai T
J Colloid Interface Sci; 2019 Sep; 551():39-46. PubMed ID: 31075632
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies on glycerol monooleate- and phytantriol-based cubosomes containing oridonin in vitro and in vivo.
Shi X; Peng T; Huang Y; Mei L; Gu Y; Huang J; Han K; Li G; Hu C; Pan X; Wu C
Pharm Dev Technol; 2017 May; 22(3):322-329. PubMed ID: 26670780
[TBL] [Abstract][Full Text] [Related]
11. Simple method for fabrication of metal-organic framework within a carboxymethylcellulose/graphene quantum dots matrix as a carrier for anticancer drug.
Pooresmaeil M; Namazi H; Salehi R
Int J Biol Macromol; 2020 Dec; 164():2301-2311. PubMed ID: 32805288
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable self-assembled MPEG-PCL micelles for hydrophobic oridonin delivery in vitro.
Xue B; Wang Y; Tang X; Xie P; Wang Y; Luo F; Wu C; Qian Z
J Biomed Nanotechnol; 2012 Feb; 8(1):80-9. PubMed ID: 22515096
[TBL] [Abstract][Full Text] [Related]
13. Metal-organic framework based drug delivery systems as smart carriers for release of poorly soluble drugs hydrochlorothiazide and dapsone.
Yadav P; Bhardwaj P; Maruthi M; Chakraborty A; Kanoo P
Dalton Trans; 2023 Aug; 52(33):11725-11734. PubMed ID: 37555452
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of galactosylated bovine serum albumin nanoparticles for liver-targeted delivery of oridonin.
Li C; Zhang D; Guo H; Hao L; Zheng D; Liu G; Shen J; Tian X; Zhang Q
Int J Pharm; 2013 May; 448(1):79-86. PubMed ID: 23518367
[TBL] [Abstract][Full Text] [Related]
15. The anti-tumor effect of folate-targeted liposome microbubbles loaded with oridonin as ultrasound-triggered tumor-targeted therapeutic carrier system.
Wang C; Li W; Hu B
J Drug Target; 2017 Jan; 25(1):83-91. PubMed ID: 27282800
[TBL] [Abstract][Full Text] [Related]
16. Multimetal organic frameworks as drug carriers: aceclofenac as a drug candidate.
Al Haydar M; Abid HR; Sunderland B; Wang S
Drug Des Devel Ther; 2019; 13():23-35. PubMed ID: 30587925
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Toxicity Study of a Porous Iron(III) Metal‒Organic Framework.
Chen G; Leng X; Luo J; You L; Qu C; Dong X; Huang H; Yin X; Ni J
Molecules; 2019 Mar; 24(7):. PubMed ID: 30925694
[TBL] [Abstract][Full Text] [Related]
18. Outstanding Drug-Loading/Release Capacity of Hollow Fe-Metal-Organic Framework-Based Microcapsules: A Potential Multifunctional Drug-Delivery Platform.
Cui R; Zhao P; Yan Y; Bao G; Damirin A; Liu Z
Inorg Chem; 2021 Feb; 60(3):1664-1671. PubMed ID: 33434431
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.
Jia L; Shen J; Zhang D; Duan C; Liu G; Zheng D; Tian X; Liu Y; Zhang Q
Int J Biol Macromol; 2012 Apr; 50(3):523-9. PubMed ID: 22301003
[TBL] [Abstract][Full Text] [Related]
20. Nanoscale Iron-Based Metal-Organic Frameworks: Incorporation of Functionalized Drugs and Degradation in Biological Media.
Christodoulou I; Lyu P; Soares CV; Patriarche G; Serre C; Maurin G; Gref R
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
